Giovanni Fattore

Giovanni Fattore is Full Professor of Health Policy at SDA Bocconi School of Management and at Bocconi University.

He was Director of the Policy Analysis & Public Management Department of Bocconi University (now Social and Political Sciences) and Director of the Master of International Healthcare Management Economics and Policy (MIHMEP) at SDA Bocconi, from 2002 to 2008, and Deputy Director of CERGAS.

His research activities focus on health policy, applied health economics, health planning & management and economic evaluation of healthcare and nutrition interventions. He worked for OECD, WHO and the World Bank and has led several research units for projects funded by the European Commission. He is Associate Editor of Health Policy Journal and author of about 130 publications in scientific journals.

Giovanni has a laurea degree in Economics from Bocconi University, a MSc from the Harvard School of Public Health and a PhD from LSE in Social Policy.

## Companies

• Professor Universita' Bocconi (2005)
• Professor SDA Bocconi (1991)
• Researcher CERGAS - Università Bocconi (1991)
• Past President Italian Association of Health Economics (AIES) (2008 — 2011)

Education

• Master of Science - MS Harvard University (1991.11 — 1993.11)
• Master of Science (MSc) Harvard University (1991 — 1993)
• Laurea in Economics Università Bocconi (1984 — 1989)

Publications

Books

• Fattore G, Mariotti G, Rebba V. Chapter 9: Italy. In Siciliani L, Borowitz M, Moran V. Witing Tim e Policies in the Health Sector: What Works. OECD Health Policies Studies. OECD publishing. 2013
• Fattore G, Ricucci N, Intergovernmental relations i n social policy. In Ongaro E, Massey A, Wayemberg E (editors). Policy Performance and Management in Governance and Intergovernmental relations. Edward Elgar 2011
• Fattore G, Tediosi F. Attaining universal health coverage: The role of governance and management. In Missoni editor, Attaining universal health coverage. Milano: Egea 2010 (31-52)
• Fattore G, Measuring Public Values. Milano: Egea. 2009
• Fattore G, Cavallo MC, Tarricone R, “Lo sviluppo del Health Technology Assessment in Italia: contenuti, approcci e riferimenti internazionali” (Health Technology Assessment in Italy). In Anessi Pessina E, Cantù E (a cura di), L’aziendalizzazione in sanità in Italia. Rapporto OASI 2008, Milano, Egea, 2008
• Fattore G, “Rilevanza e complessità delle amministrazioni pubbliche” (Relevance and complexity of public institutions). In Borgonovi E., Fattore G., Longo., F. (a cura di), Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (3-16)
• Borgonovi E, Fattore G, “I concetti fondamentali per lo studio delle amministrazioni pubbliche” (Fundamentals in the study of public management). In Borgonovi E, Fattore G, Longo F, Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (17-32)
• Fattore G, “Le funzioni delle istituzioni pubbliche” (Main functions of public institutions). In Borgonovi E., Fattore G., Longo., F. Management delle Istituzioni Pubbliche, Milano, Egea, 2008 (33-46)
• Borgonovi E, Fattore G “Caratteristiche e specificità del management pubblico” (Peculiarity of public management) . In Borgonovi E, Fattore G, Longo F. Management delle Istituzioni Pubbliche, Milano, Egea 2008 (47-62)
• Bartoli S, Fattore G “Italia ed Europa, un confronto in sanità: il progetto EU Health Basket”, (Italy and Europe: results from the Health Basket project). In Anessi Pessina E, Cantù E., L''aziendalizzazione in sanità in Italia. Rapporto OASI 2007, Milano, Egea, 2007
• “I Piani Sanitari Nazionali: quale ruolo per lo Stato nella programmazione di un sistema decentrato”, In Anessi Pessina E, Cantù E., L''aziendalizzazione in sanità in Italia. Rapporto OASI 2006, Milan, Egea, 2006 (con, Aguzzi G., Lecci F.)
• "Prefazione”. Spar D. Baby Business, Egea, Milano, 2006
• “I piani sanitari delle Regioni italiane”. In Anessi Pessina E, Cantù E., L''aziendalizzazione in sanità in Italia. Rapporto OASI 2005, Milan, Egea, 2005 (con F. Lecci)
• Metodi di ricerca in economia aziendale, Milan, Egea, 2005
• “L’aziendalizzazione della sanità in Italia: la prospettiva dei consulenti”. In Anessi Pessina E, Cantù E., L''aziendalizzazione in sanità in Italia. Rapporto OASI 2004, Milan, Egea, 2004
• “Innovazione di processo, knowledge practice e performance assistenziali: il caso dell’Ospedale degli Infermi di Biella”. In AA. VV. Knowledge Management e Successo Aziendale. Atti del 26° Congresso Aidea. Agf AIDEA, Udine, 2004 (con V. Tozzi)
• "Assetti federali in Sanità: cosa possiamo imparare da Canada e Stati Uniti?" In Falcitelli N, Trabucchi M, Vanara F. (a cura di), Rapporto Sanità 2003. Il governo dei sistemi sanitari tra programmazione, devolution e valorizzazione delle autonomie, Bologna, Il Mulino, 2003

Articles (Selection)

• Fattore G, Petrarca G, Torbica A. Traveling for care: Inter-regional mobility for aortic valve substitution in Italy. Health Policy 2014
• Torbica A, Fattore G, Ayala F. Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis. Pharmacoeconomics 2014; 32(2)
• Boriani G, Maniadakis N, Auricchio A, Müller-Riemenschneider F, Fattore G, Leyva F, Mantovani L, Siebert M, Willich SN, Vardas P, Kirchhof P. Health technology assessment in interventional electrophysiology and device therapy: A position paper of the European Heart Rhythm Association. European Heart Journal 2013; 34(25): 1869-1874
• Häkkinen U, Iversen T, Peltola M, Seppälä TT, Malmivaara A, Belicza E, Fattore G, Numerato D, Heijink, R, Medin E, Rehnberg C. Health care performance comparison using a disease-based approach: The EuroHOPE project. Health Policy 2013; 11(1-2): 100-109
• Agostoni C, Fattore G. Growth outcome: Nutritionist perspective. World Review of Nutrition and Dietetics 2013; 106: 12-18
• Fattore G, Tediosi F. The importance of values in shaping how health systems governance and management can support universal health coverage. Value in Health 2013; 16: (1 SUPPL.) S19-S23
• De Belvis AG, Ferrè F, Specchia ML, Valerio L, Fattore G, Ricciardi W. The financial crisis in Italy: Implications for the healthcare sector; Health Policy 2012; 106(1): 10-16
• Numerato D, Salvatore D, Fattore G. The impact of management on medical professionalism: A review. Sociology of Health and Illness 2012; 34 (4): 626-644 
• Linertová, R., Serrano-Aguilar, P., Posada-de-la-Paz, M., Hens-Pérez, M., Kanavos, P., Taruscio, D., Schieppati, A., Stefanov, R., Péntek, M., Delgado, C., Graf von der Schulenburg, J.-M., Persson, U., Chevreul, K., Fattore, G., Worbes-Cerezo, M., Sefton, M., López-Bastida, J. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy 2012; 108(1): 19-26
• Fattore G, Dubois HFW, Lapenta A. Measuring New Public Management and Governance in Political Debate. Public Administration Review 2012; 72 (2): 218-227
• Gandini F, Giannitti C, Fattore G, Giordano N, Galeazzi M, Fioravanti A. Validation of an Italian version of the functional index for hand osteoarthritis (FIHOA). Modern Rheumatology 2012; 22(5): 758-765 
• Karampampa, K., Gustavsson, A., Miltenburger, C., Teruzzi, C., Fattore, G. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Italy. Multiple sclerosis 2012: 18(2 Suppl): 29-34 
• Fattore, G., Lang, M., Pugliatti, M. The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis. Multiple sclerosis 2012; 18 (2 Suppl): 5-6 
• Casey GJ, Sartori D, Horton SE, Phuc TQ, Phu LB, Thach DT, Dai TC, Fattore G, Montresor A, Biggs BA. Weekly iron-folic acid supplementation with regular deworming is cost-effective in preventing anaemia in women of reproductive age in Vietnam. PLoS ONE 2011; 6(9): e23723 
• Dubois, H.F.W., Fattore, G. Public Fund Assignment through Project Evaluation. Regional and Federal Studies 2011; 21(3): 355-374 
• Fattore G, Maniadakis N, Mantovani LG, Boriani, G. Health technology assessment: What is it? Current status and perspectives in the field of electrophysiology. Europace 2011; 13 (SUPPL. 2): ii49-ii53 
• Boriani G, Burri H, Mantovani LG, Maniadakis N, Leyva F, Kautzner J, Lubinski A, Braunschweig F, Jung W, Lozano IF, Fattore, G. Device therapy and hospital reimbursement practices across European countries: A heterogeneous scenario Europace 2011; 13 (SUPPL. 2): ii59-ii65 
• Maniadakis, N., Vardas, P., Mantovani, L.G., Fattore, G., Boriani, G. Economic evaluation in cardiology. Europace 2011; 13 (SUPPL. 2): ii3-ii8 
• Calciolari S, Cantù E, Fattore G. “Performance management and goal ambiguity: Managerial implications in a single payer system” Health Care Management Review 2011; 36(2): 164-174 
• Fattore G, Salvatore D. “Network organizations of general practitioners: antecedents of formation and consequences of participation”. BMC Health Service Research 2010; May 11; 10(1): 118 
• Torbica A, Fattore G. “Understanding the impact of economic evidence on clinical decision making: a discrete choice experiment in cardiology”, Social Science and Medicine 2010; 70: 1536-1543 
• Cappellaro G, Fattore G, Torbica A. “Funding and Regulating Health Technologies in Decentralized Systems: A Comparison between Italy and Spain”, Health Policy 2009; 92(3) 313-321 
• Fattore G, Frosini F, Salvatore D, Tozzi V. “Social Network Analysis in Primary Health Care: the impact of interaction on prescribing behaviour”, Health Policy 2009; 92(3): 141-148 
• Dubois H, Fattore G. “Definitions and typologies in public administration research: The case of decentralization”, International Journal of Public Administration 2009; 32(8): 704-727 
• Pacileo G, Fattore G. “Alcool abuse prevention in young people: an economic simulation”, Journal of Substance Abuse 2009; 6: 385-392 
• Gerzeli S., Torbica A, Fattore G. “Cost Utility Analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputees”, The European Journal of Health Economics (HEPAC) 2008; 2: 327-336 
• Fattore G, Jommi C “The last decade of Italian pharmaceutical policy: instability or consolidation?” Pharmacoeconomics 2008; 26(1):5-15 
• Fattore G, Torbica A “Cost and reimbursement of cataract surgery in Europe: a cross-country comparison”, Health Economics, 2008; 17 (S1): S71-S82 
• Compagni A, Bartoli S, Buehrlen B, Fattore G, Ibarreta D, de Mesa EG “Avoiding adverse drug reactions by pharmacogenetic testing: A systematic review of the economic evidence in the case of TPMT and AZA-induced side effects. International Journal of Technology Assessment in Health Care 2008; 24(3): 292-302 
• Fattore G, Factors Affecting an Economic Model for Zoster Vaccination, Herpes 2007; 14 (S2): 52A-55A 
• Fattore G, Torbica A “Inpatient reimbursement system in Italy: How do tariffs relate to costs?” Health Care Management Science 2006; 9: 251-258 
• Fattore G, Torbica A. “Economic evaluation in health care: the point of view of informed physicians”, Value in Health 2006; 9(3): 157-167 
• Torbica A, Fattore G. “The "Essential Levels of Care" in Italy: when being explicit serves the devolution of powers”, The European Journal of Health Economics (HEPAC) 2005; 6: 46-52 
• Amato, MP, Battaglia MA, Caputo D, Fattore G, Gerzeli S, Pitaro M, Reggio A “The costs of multiple sclerosis: a cross-sectional, multicenter cost-of-illness study in Italy”, Journal of Neurology 2002; 249(2): 152-163 
• Percudani M, Fattore G, Belloni GC, Gerzeli S, Contini A “Service utilization and costs of first-contact patients in a community psychiatric service in Italy”, European Psychiatry 17 (8); 2002: 434-442 
• Fattore G, Percudani M, Pugnoli C, Contini A, Beecham J “Mental Health Care in Italy: Organisational Structure, Routine Clinical Activity and Costs of a Community Service in Lombardy Region”, International Journal of Social Psychiatry 2000; 46(4): 250-265
• Tarricone R, Fattore G, Gerzeli S, Taddei C, Percudani M, “Costs of pharmaceutical treatments in major depression patients in Italy” Pharmacoeconomics 2000; 15: 245-260 
• Fattore G, “Clarifying the scope of Italian NHS coverage: Is it feasible? Is it desirable?” Health Policy 1999; 50: 123-142 
• Percudani M, Fattore G, Galletta J, Mita P, Altamura C “Health care costs of therapy-refractory schizophrenic patients treated with clozapine: a study in a Community Psychiatric Service in Italy”, Acta Psychiatrica Scandinavica 1999; 99: 274-280
• Fattore G, Jommi C, “The New Pharmaceutical Policy in Italy”, Health Policy 1998; 46 (1); 21-41 
• Lorenzoni R, Pagano D, Mazzotta G, Rosen D, Fattore G, Gensini G, “Pitfalls in the economic evaluation of thrombolysis in myocardial infarction”, European Heart Journal 1998; 19(10): 1518-1524 
• Cavallo M C, Fattore G “The Economic and Social Burden of Alzheimer Disease on Families in Lombardy Region, Italy”, Alzheimer Disease and Associated Disorders 1997; 11(4): 184-190 
• Villari P, Fattore G, Siegel J, Paltiel D, Weinstein M, "Economic Evaluation of HIV Testing Among Intravenous Drug Users: Analytic Framework and Application to Italy", International Journal of Technology Assessment in Health Care, 1996; 12(2): 329-350